Results 91 to 100 of about 6,661 (116)

Stima dei pazienti potenzialmente eleggibili alla terapia con icosapent etile in Italia mediante revisione dei dati di letteratura. [PDF]

Glob Reg Health Technol Assess
Filardi PP, Arcangeli E, Carullo P, Galeone C, Arca M.   +4 more
europepmc   +1 more source

A new database of chestnut DNA fingerprints for genetic diversity assessment, precise varietal identification, and traceability. [PDF]

Database (Oxford)
Fruggiero I, Maisto A, Passaro S, Gentile D, Nunziata A, D'Agostino N.   +5 more
europepmc   +1 more source

[Analysis of the performance of public and private hospitals serving the Brazilian Unified National Health System]. [PDF]

Cad Saude Publica
Panitz LM, Prata DN, Rodrigues W.
europepmc   +1 more source

Pathological Deficit of Cystatin B Impairs Synaptic Plasticity in EPM1 Human Cerebral Organoids. [PDF]

Mol Neurobiol
Pizzella A, Penna E, Abate N, Frenna E, Canafoglia L, Ragona F, Russo R, Chambery A, Perrone-Capano C, Cappello S, Crispino M, Di Giaimo R.   +11 more
europepmc   +1 more source

Squirting Cucumber, Ecballium elaterium (L.) A. Ritch: An Update of Its Chemical and Pharmacological Profile. [PDF]

Molecules
Anzano A, Falco B, Grauso L, Lanzotti V.
europepmc   +1 more source

[Validation of a questionnaire on knowledge, attitudes, and healthcare approaches to female genital mutilation among nursing students: A pilot study]. [PDF]

An Sist Sanit Navar
Pastor Bravo MDM, Martínez Jurado YM, Ayad Ouchen S.   +2 more
europepmc   +1 more source

[Causes of Patient Referral by Community Pharmacists in Madrid: An Analysis of the Conexión Futuro Study].

Farm Comunitarios
Bonilla Guijarro A, Fernández Otero MD, Tejedor García N, Ordóñez Iriarte JM, Aguilar Ros A.   +4 more
europepmc   +1 more source

[Childhood family strengths and cardiometabolic risk in adults from a clinical setting of Michoacán, Mexico]. [PDF]

Aten Primaria
Hipólito Mendoza HV, Gómez Garcia A, Ibarra Rojas L, Chacón-Valladares P, Lajud N.   +4 more
europepmc   +1 more source

La cooperazione tra gli stakeholder per la sostenibilità del nuovo paradigma farmaceutico in Italia. [PDF]

Glob Reg Health Technol Assess
Drago V, Di Brino E, Laurita R, Rumi F, Basile M, Pierini A, Ponzianelli A, Patarnello F, Ianna P, Drago F.   +9 more
europepmc   +1 more source